be aware! market starts to sell-off now! pharmaceutical giant Merck & Co. fell more than 6% Thursday on news that the company is discontinuing a key clinical trial and modifying a second for its much-anticipated blood-thinner vorapaxar at the recommendation of the study’s monitoring board.
Market Data 
Markets 
AI
